Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220413 · ClinicalTrials.gov registry record
Predictors of Lactogenesis II
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 216
- Enrollment target
NCT02220413: Completed study, sponsored by University of South Florida.
NCT02220413 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 216 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02220413 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II. We will compare two group of women for delayed lactogenesis II, one group with obese women (BMI\>30) and one group of women with a normal weight (BMI\<30). The secondary objective is to assess what other factors influence the self-reported delayed lactogenesis II.
Primary Outcome
Women will be asked about the perception of the onset of their breastmilk coming such as breast engorgement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-01-01 |
What the finished NCT02220413 record still lists
NCT02220413 is an observational study that tracks outcomes without assigning an intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02220413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02220413 about?
NCT02220413 is a clinical study titled "Predictors of Lactogenesis II". The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II. We will compa...
What is the current status of trial NCT02220413?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2014-08. Estimated completion is 2017-01-01.
Who is sponsoring clinical trial NCT02220413?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia